Showing results (31-40 of 51) with videos related to

Sort By:
Pageof 6
Journal of Chemical Theory and Computation|February 26, 2016
Importance of Three-Body Interactions in Molecular Dynamics Simulations of Water Demonstrated with the Fragment Molecular Orbital MethodSpencer R Pruitt, Hiroya Nakata, Takeshi Nagata, et al.
Genes & Development|August 19, 2008
Genetic identification of yeast 18S rRNA residues required for efficient recruitment of initiator tRNA(Met) and AUG selectionJinsheng Dong, Jagpreet S Nanda, Hafsa Rahman, et al.
Carcinogenesis|July 5, 2013
Macrophage migratory inhibitory factor promotes bladder cancer progression via increasing proliferation and angiogenesisShilpa Choudhary, Poornima Hegde, James R Pruitt, et al.
Alimentary Pharmacology & Therapeutics|October 13, 2010
Clinical trial: once-daily mesalamine granules for maintenance of remission of ulcerative colitis - a 6-month placebo-controlled trialG R Lichtenstein, G L Gordon, S Zakko, et al.
American Journal of Medical Genetics|June 1, 1989
Clinical, pathological, and biochemical studies on an infantile case of sulfatide/GM1 activator protein deficiencyD A Wenger, G DeGala, C Williams, et al.
Bioorganic & Medicinal Chemistry Letters|April 27, 2000
Isoxazolines and isoxazoles as factor Xa inhibitorsJ R Pruitt, D J Pinto, M J Estrella, et al.
Gastroenterology|August 28, 1998
Budesonide enema for the treatment of active, distal ulcerative colitis and proctitis: a dose-ranging study. U.S. Budesonide enema study groupS B Hanauer, M Robinson, R Pruitt, et al.
Bioorganic & Medicinal Chemistry Letters|January 1, 1999
Rational design of boropeptide thrombin inhibitors: beta, beta-dialkyl-phenethylglycine P2 analogs of DuP 714 with greater selectivity over complement factor I and an improved safety profileJ M Fevig, J Buriak, J Cacciola, et al.
Journal of Clinical Microbiology|October 19, 1999
Rapid identification of Candida dubliniensis with commercial yeast identification systemsD H Pincus, D C Coleman, W R Pruitt, et al.
Iscience|December 4, 2024
Distinct effects of sacituzumab govitecan and berzosertib on DNA damage response in ovarian cancerJayakumar R Nair, Tzu-Ting Huang, Anu Sunkara, et al.
Pageof 6